HemaCare Corporation

HemaCare is a global leader in providing human-derived biological products and apheresis collection services, directly enabling customers to advance autologous and allogeneic cell therapies. With over 40 years of experience, HemaCare has performed over 300,000 apheresis collections, developed the largest registry of healthy, repeat donors, and adopted the most stringent quality standards in the industry to provide customers with the highest quality starting material and primary cells available today. HemaCare is also the first commercial provider of GMP-compliant human primary cells isolated from leukopaks and bone marrow collected onsite. Our GMP-compliant materials are collected following consistent collection procedures and processes, ensuring the highest quality GMP starting material to support global cell therapy from product and process development to commercialization. HemaCare’s GMP capabilities include: • Leukopak and Bone Marrow Aspirate collections • Cell processing and isolation within a clean room environment (T cells, NK cells, etc.) • Cryopreservation and storage • Customization of collection and services to meet protocol specifications • Technology transfer of client-specific protocols for GMP To learn more about HemaCare’s role in commercializing patient cell therapies and how we may be able to assist you on your next project, please contact us at https://www.hemacare.com/contact/. Connect with HemaCare Online: Visit HemaCare’s Website: https://www.hemacare.com/ Follow HemaCare on LinkedIn: https://bit.ly/314zF81 Follow HemaCare on Twitter: https://bit.ly/2Y9qAxs Follow HemaCare on Facebook: https://bit.ly/32TIjrF

HemaCare, A Charles River Company: Cell Therapy Solutions

Learn how HemaCare’s vertically integrated solutions support research from the bench to bedside. This video highlights HemaCare’s state-of-the-art facility, and gives an overview of how HemaCare’s over 40 years of donor management expertise and apheresis collection experience play a crucial role in providing high quality cellular material for the development cell-based therapies. HemaCare has performed over 300,000 apheresis collections, developed the largest reliable and recallable donor pool, and adopted the most stringent quality standards in the industry to provide customers with the highest quality cells and tissues available today. As a result, HemaCare was involved with 100% of FDA-approved immunotherapies. HemaCare is committed to providing a best-in-class portfolio of high quality, customizable human cellular material and services to advance discoveries.

HemaCare Corporation

Home

Videos

Playlists

About

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.